Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Open or close the search fields display
182 Studies found for: Venetoclax

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
Venetoclax 182 studies 182 studies
ABT-199 110 studies 110 studies
GDC-0199 73 studies 73 studies
Venclexta 62 studies 62 studies
ABT-0199 33 studies 33 studies
RG7601 32 studies 32 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym

Related Terms:

Click on a related term to refine your search.
This will narrow your search by adding an additional search term.
If your search becomes too narrow (finds too few studies), broaden it by removing search terms with the Modify Search page.

A ABT-
ABT-0199
ABT-199
Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
AML
Acute Myeloid Leukemia (AML)
B B-Cell
Bcl-
Bcl-2
Bendamustine
C cell lymphoma
cells
B-Cell
cell lymphoma
Chronic
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
CLL
Chronic Lymphocytic Leukemia (CLL)
combination
complete
complete remission
complete response
CRi
cycle
G GDC-
GDC-0199
I Ibrutinib
L Leukemia
Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
Myeloid Leukemia
Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Lymphocytic
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
Lymphoma
cell lymphoma
Non-Hodgkin's Lymphoma
M marrow
minimal residual disease
Myeloid
Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Myeloid Leukemia
Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
N Non-Hodgkin's Lymphoma
O Obinutuzumab
overall
Overall Response
P PFS
Phase
progression
R Refractory
Relapsed
residual disease
minimal residual disease
response
complete response
Overall Response
response rate
RG7601
Rituximab
S survival
V Venclexta
Venetoclax